Each day workers in the health care field debate the most reliable course of action for treating a particular ailment. As part of U.S. health care reform new emphasis is being placed on comparative effectiveness research (CER) which pits remedies against one another to determine which is best. A new paper by Wharton professor Scott Harrington warns that the government should avoid developing a monopoly on CER and offers suggestions for sparking interest from private sector researchers.
Hosted on Acast. See acast.com/privacy for more information.
Knowledge at Wharton